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Abstract
Alcoholism has been associated with folate deficiency in humans and laboratory animals. Previous study showed that ethanol feeding reduces 
the dehydrogenase and hydrolase activity of 10-formyltetrahydrofolate dehydrogenase (FDH) in rat liver. Hepatic ethanol metabolism generates acetaldehyde
and acetate. The mechanisms by which ethanol and its metabolites produce toxicity within the liver cells are unknown. We purified FDH from 
rat liver and investigated the effect of ethanol, acetaldehyde and acetate on the enzyme in vitro. Hepatic FDH activity was not reduced by ethanol
or acetate directly. However, acetaldehyde was observed to reduce the dehydrogenase activity of FDH in a dose- and time-dependent manner with
an apparent IC50  of 4 mM, while the hydrolase activity of FDH was not affected by acetaldehyde in vitro. These results suggest that the inhibition
of hepatic FDH dehydrogenase activity induced by acetadehyde may play a role in ethanol toxicity.
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Introduction1)
Prolonged consumption of excessive amounts of alcohol alters 
folate metabolism in the liver (Horne et al., 1978; Min et al., 
2005; Tamura & Halsted, 1983). Recently, we showed that 
ethanol feeding decreases 10-formyltetrahydrofolate dehydrogenase 
(FDH; EC 1.5.1.6.) activity in rat liver and suggested that the 
inhibition of FDH appears to explain partly a defect of folate 
metabolism elicited by chronic ethanol ingestion (Im et al., 1998; 
Min  et al., 2005). 
FDH is an enzyme that catalyzes the oxidation of formyl group 
of 10-formyltetrahydrofolate (10-FTHF) to CO2 in an NADP
+- 
dependent dehydrogenase reaction or an NADP
+-independent 
hydrolase reaction (Kutzbach & Stokstad, 1971). The enzyme 
is also known as an abundant high affinity folate-binding protein 
in liver (Cook & Wagner, 1995; Min et al., 1988), a multi-domain 
enzyme consisting of three domains (Cook et al., 1991; Krupenko 
et al., 1997), and protein-arginine N-methyltransferase activity 
(Kim et al., 1998). The NADP
+-independent hydrolase reaction 
occurs in N-terminal domain of FDH, converting to 10-formyl 
THF to THF and formate, whereas the C-terminal domain is 
aldehyde dehydrogenase-homologous enzyme capable of NADP
+- 
dependent oxidation (Krupenko et al., 1997). Recently, Donato 
et al. (2008) demonstrated the intermediate domain of FDH as 
a member of the group of carrier protein with a 4’-phosphopan-
tetheine swinging arm, transferring formyl group between two 
catalytic domains. 
Many of the effects caused by the action of ethanol are actually 
mediated by its metabolites, namely acetaldehyde and acetate 
(Israel et al., 1994; Kenyon et al., 1998). Ethanol is metabolized, 
via three metabolic pathways, to acetaldehyde and to acetate in 
liver: the cytosolic enzymes alcohol dehydrogenase (ADH) and 
aldehyde dehydrogenase, the microsomal ethanol oxidizing system 
(MEOS: cytochrome P450 2E1) and catalase in both peroxisomes 
and mitochondria (Agarwal, 2001). Generally, acetaldehyde is 
formed by the action of ADH in liver. However, when ethanol is 
chronically ingested, cytochrome P450 2E1 (CYP2E1) pathway 
is induced (Lieber, 1990) and produces much higher concentrations 
of acetaldehyde (Eriksson & Sippel, 1977). Thus, CYP2E1 induction 
explains the tolerance to alcohol seen in alcoholics as well (Lieber, 
1990). 
Since decreased FDH activity in vivo by chronic ethanol 
feeding has been implicated as a toxic effect of ethanol and the 
action of ethanol may originate from ethanol itself or its metabolites 
including acetaldehyde and acetate, we investigated the mechanism 
of this inhibition further in vitro. In this study, purified rat liver 
FDH was used to test in vitro effect of ethanol and its metabolites, 
acetaldehyde and acetate, in time- and dose-dependent studies. 
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During this investigation, we found that acetaldehyde inhibited 
FDH whereas ethanol itself did not inhibit the enzyme. 
Materials and Methods
Materials
Sephacryl S-300, DEAE-Sephadex A-50 and Blue Sepharose 
6 Fast Flow were obtained from Amersham Biosciences 
(Piscataway, NJ, USA). Ethanol, acetaldehyde and acetate were 
purchased from Merck (Whitehouse Station, NJ, USA). Bradford’s 
reagent was obtained from Bio-Rad (Hercules, CA, USA) and 
[6RS]-10-formyltetrahydrofolate was prepared fresh daily from 
[6RS]-5-formyltetrahydrofolate from Sigma (St. Louis, MO, 
USA). All chemicals were of the highest purity commercially 
available.
Purification of 10-formyltetrahydrofolate dehydrogenase
Rat livers were removed from Sprague-Dawley rats weighing 
250~280 g. FDH was purified from rat liver by the procedure 
of Scrutton and Beis (1979) with slight modification. Briefly, 
the liver homogenate was chromatographed on Sephacryl S-300, 
followed by DEAE-Sephadex A-50active enzyme fractions were 
then pooled and further purified by Blue Sepharose 6 Fast Flow 
chromatography. Enzyme with specific activity 0.5 μmol/min/mg 
protein was used in this study. 
Assay of 10-formyltetrahydrofolate dehydrogenase and hydrolase 
activities
The activity of FDH dehydrogenase was assayed by the procedure 
of Kutzbach and Stokstad (1971). Assay reaction mixtures (total 2 
mL) contained 50 mM Tris-HCl, pH 7.7, 100 mM 2-mercap-
toethanol, 100 μM NADP
+, 75 μM [6RS]-10-FTHF, and aliquots 
of ethanol, acetate, or acetaldehyde when required, plus the enzyme 
source. Incubations (30℃) were performed for 3 min and the 
reaction was terminated by cooling the assay mixture in ice-water 
bath. The formation of THF was monitored by measuring the increase 
in A300nm produced by the conversion of 10-FTHF to THF. A 
millimolar extinction coefficient (corrected for the contribution 
of NADPH) of 22.6 cm
-1 was used. Readings were measured 
against reaction solutions containing no enzyme or no substrate. 
The activity of FDH hydrolase was assayed by the same methods 
as FDH dehydrogenase assay in the absence of NADP
+.
Protein assay 
Protein concentration was determined according to the method 
of Bradford (1976) using bovine serum albumin as a standard. 
The absorbance at 280 nm was used to monitor protein in the 
column effluents.
Inhibition studies for FDH activity by ethanol, acetaldehyde and 
acetate
Purified enzyme was preincubated in 50 mM Tris-HCl buffer, 
pH 7.7 in the presence or absence of ethanol, acetaldehyde or 
acetate to test for enzyme inhibition. Preliminary experiments 
were carried out to establish optimal conditions. To determine 
the percentage inhibition, FDH activities from the compound- 
incubated mixtures were compared to control assays containing 
equivalent enzyme concentrations in the absence of the compounds. 
The time-dependent effect of acetaldehyde on FDH activity was 
analyzed by incubating the purified enzyme in the presence of 
2 or 6 mM acetaldehyde at 4℃ for up to 2 hr. The concentrations 
of acetaldehyde were chosen because free acetaldehyde levels 
in liver is reported as 250 μM in rats administered ethanol orally 
(Eriksson & Sippel, 1977) and some acetaldehyde is bound to 
proteins in liver, so in vivo hepatic acetaldehyde concentrations 
may be higher than these values. Blood acetaldehyde concentrations 
are higher in the rat than in humans (Kenyon et al., 1998). Since 
inhibitory activities of acetaldehyde on the dehydrogenase 
activity of FDH at 4℃  were similar at 37℃  (Fig. 1) and 
acetaldehyde is volatile, we incubated the enzyme with the agents 
at 4℃. The hepatic ethanol concentrations were observed as up 
to 50 mM (Eriksson & Sippel, 1977).
Acetaldehyde solutions were prepared and stored on ice to 
avoid loss of the material and incubation was performed in 
light-protected tubes with stoppers. The concentrations of 
acetaldehyde producing 50% inhibition of the enzyme activity 
(IC50) was calculated from the least-squares regression line of 
the logarithmic concentrations plotted the remaining activity. 
Results
The dehydrogenase activity of purified rat liver FDH was tested 
in the presence of ethanol, acetate, or acetaldehyde (Table 1). 
When FDH was incubated with ethanol for 30 min at 4℃, ethanol 
had no significant effect on the dehydrogenase activity at 
concentrations between 10 and 500 mM. However, the dehydro-
genase activity was slightly increased in the presence of acetate 
with concentrations between 10 and 100 mM, possibly reflecting 
the buffering capabilities of acetate. In contrast to ethanol and 
acetate, acetaldehyde was found to reduce the dehydrogenase 
activity of FDH in a concentration dependent way with concentra-
tions between 1 mM and 8 mM acetaldehyde at 4℃ (Table 1). 
As shown in Fig. 1, acetaldehyde reduced the dehydrogenase 
activity of FDH at 37℃ similar to at 4℃ (Fig. 1).
The inhibitory effects of acetaldehyde on the dehydrogenase 
activity of FDH were plotted over 120-min time course in Fig. 
2. When FDH was incubated in the presence of 2 mM or 6 mM 
acetaldehyde at 4℃, acetaldehyde reduced the dehydrogenase 
activity of FDH immediately and the inhibition developed in full 
within 120 min in this experimental condition (Fig. 2). The Ju-Ae Mun et al. 197
Table 1. Effects of ethanol, acetate and acetaldehyde on the dehydrogenase
activity of FDH in vitro
Compounds Concentration (mM) % Change in FDH activity
1)
Ethanol 10 + 5.4 ± 3.2
50 + 9.6 ± 8.8
100 - 6.5 ± 8.2
500 + 8.8 ± 5.9
Acetate 10 + 2.1 ± 2.4
50 + 19.7 ± 7.5
100 + 12.1 ± 9.0
Acetaldehyde 1 - 19.8 ± 4.9
2 - 30.5 ± 5.4
4 - 50.3 ± 4.2
6 - 61.1 ± 6.4
8 - 87.8 ± 10.3
1) P u r i f i e d  F D H  w a s  p r e i n c u b a t e d  w i t h  each  compound  for  30  min  at  4℃.  FDH 
dehydrogenase  activity  was  estimated  by  THF  production  at  300  nm  in  the 
presence of NADP
+ and then by subtracting hydrolytic rate from total rate. Each 
value represents the mean of triplicate estimates of THF production and expressed 
as  a  percentage  with  respect  to  a  control  containing  equivalent e n z y m e  
concentration  and  no  compound.
Fig. 1. Effects of temperature on the dehydrogenase activity of FDH during 
incubation in the presence of acetaldehyde in vitro. Purified FDH was incubated 
in the presence of various concentrations of acetaldehyde at 4℃ and 37℃ . FDH 
dehydrogenase activity was estimated by THF production at 300 nm in the presence 
of  NADP
+  and  then  by  subtracting  hydrolytic  rate  from  total  rate.  Each  point 
represents  the  mean  of  triplicate  estimates  of  THF  production  an d  e x p r e s s e d  a s 
a percentage with respect to a control containing equivalent enzyme concentration 
and  no  acetaldehyde.
Fig. 2. Effects of acetaldehyde on FDH dehydrogenase activity over time in 
vitro. Purified FDH was incubated in the presence of 2 mM or 6 mM acetaldehyde 
at 4℃. FDH dehydrogenase activity was estimated by THF production at 300 nm 
in the presence of NADP
+ and then by subtracting hydrolytic rate from total rate. 
Each  point  represents  the  mean  of  triplicate  estimates  of  THF  production. 
Fig. 3. Effects of acetaldehyde concentration on the dehydrogenase and 
hydrolase activities of FDH in vitro. Purified FDH was incubated in the presence 
of  various  concentrations  of  acetaldehyde  at  4℃.  Dehydrogenase  (DH) activity of 
FDH was estimated by THF production at 300 nm in the presence of NADP
+ and 
then by subtracting hydrolytic rate from total rate. Hydrolase activity was estimated
by THF production at 300 nm in the absence of NADP
+. Each point is the mean 
of triplicate estimates of the activities and expressed as a percentage activity with 
respect  to  a  control  containing  equivalent  enzyme  concentration a n d  n o  
acetaldehyde.
dehydrogenase activities of FDH observed in the presence of 6 
mM acetaldehyde were approximately 40 to 60 % lower than 
the activities observed at 2 mM acetaldehyde during 120 min. 
The effect of various concentrations of acetaldehyde on the 
dehydrogenase and hydrolase activity of FDH was investigated 
with purified rat liver enzyme. The purified enzyme was incubated 
with 0 to 20 mM acetaldehyde for 30 min at 4℃ and the enzyme 
activities were measured (Fig. 3). Acetaldehyde reduced the 
dehydrogenase activity of FDH with an apparent IC50 of 4 mM. 
When higher concentration of acetaldehyde (≥10 mM) was 
utilized, the enzyme activity was nearly completely inactivated. 
In contrast to the inhibitory effect on the dehydrogenase activity 
of FDH, acetaldehyde had essentially no effect on the rate of 
hydrolase activity of FDH with concentrations up to 20 mM
  as 
determined by production of THF at 300 nm in the absence of 
NADP
+  under standard assay conditions (Fig. 3). 
Discussion
Ethanol has long been known to have hepatotoxic effects, even 
at relatively low doses. Oxidation of ethanol produces acetaldehyde, 
a highly reactive compound that may contribute to the toxic effect 
of ethanol in liver (Diehl, 2002; Neuman et al., 2001). The 
enzymes that are believed to be primarily responsible for the 
oxidation of ethanol are alcohol dehydrogenase, catalase, and 
cytochrome P450 2E1 (CYP2E1) (Agarwal, 2001; Oneta et al., 
2002). 
It has been extensively documented that in vivo inhibition of 
methionine synthase induced by ethanol plays a critical role in 198 10-formyltetrahydrofolate dehydrogenase and acetaldehyde
hepatotoxicity and the administration of ethanol depletes hepatic 
S-adenosylmethionine which protects the liver from ethanol- 
induced fatty infiltration (Barak et al., 2001; Barak et al., 2003). 
In vitro study with rat liver methionine synthase has demonstrated 
that inactivation of methionine synthase was induced by 
acetaldehyde and ethanol did not inhibit methionine synthase 
directly (12) (Kenyon et al., 1998). 
We recently observed that chronic ethanol ingestion decreased 
the hepatic activities of FDH by 46% in rats fed folate-sufficient 
diets and by 79% in rats fed folate-deficient diets compared to 
the ethanol-free diet groups (Im et al., 1998; Min et al., 2005). 
The physiological importance of FDH is established as an 
abundant folate-binding protein in liver cell (Cook & Wagner, 
1995; Min et al., 1988) and a multifunctional enzyme that has 
three catalytic activities: 1) the NADP
+-dependent oxidation of 
10-FTHF, 2) the NADP
+-independent hydrolysis of 10-FTHF, 
and 3) the NADP
+-dependent oxidation of propanal (Cook et al., 
1991; Schirch et al., 1994). In the present study, ethanol, its 
metabolites acetaldehyde, and acetate were tested to determine 
their effects on purified rat liver FDH in vitro. Our results 
demonstrated that acetaldehyde reduced the dehydrogenase 
activity of FDH whereas ethanol and acetate did not induce any 
significant inhibition. 
The ability of acetaldehyde to inhibit FDH dehydrogenase 
activity was investigated over time-course by incubating FDH 
with 2 mM or 6 mM acetaldehyde (Fig. 2). The time-dependent 
experiment revealed that the dehydrogenase activity was 
inactivated within 1 min, which indicated that the interaction 
between FDH and acetaldehyde may occur immediately. Dose- 
dependent study showed that the IC50 for the interaction of FDH 
and acetaldehyde was 4 mM. However, this concentration is not 
physiologically relevant concentration because free acetaldehyde 
concentration in rat is reported as 250 nmol/g in liver and 150 
μM in the blood (Eriksson & Sippel, 1977). However, the actual 
concentrations in our in vitro system may be much lower than 
our reported values because acetaldehyde is highly volatile. 
Furthermore, it is not uncommon to use such concentrations in 
the in vitro studies (Blasiak et al., 2000; Kenyon et al., 1998; 
Rouach et al., 2005). Thus it may be reasonable to assume that 
this kind of in vitro assay could represent an acute treatment 
for a short time although the in vitro data cannot be directly 
extrapolated to the in vivo situation (Hard et al., 2001). On the 
other hand, the higher concentrations of acetaldehyde can be 
achieved by induction of chytochrome P450 2E1 when ethanol 
is chronically ingested (Agarwal, 2001; Oneta et al., 2002).
We found that hepatic FDH dehydrogenase activity was 
reduced by acetaldehyde in vitro but hydrolase activity was 
apparently not affected by acetaldehyde in vitro (Fig. 3). This 
observation was different from previous reports in which both 
dehydrogenase and hydrolase activities of FDH were reduced by 
chronic ethanol consumption in rats (Im et al., 1998; Min et 
al., 2005). Since hydrolase reaction of FDH produces THF when 
hepatic NADP
+ levels are low, the hydrolase reaction is proposed 
as the enzymatic activity used to produce THF irrespective of 
the redox state of the cell (Rios-Orlandi et al., 1986). However, 
Krupenko  et al. (1995) reported that the hydrolase reaction 
requires millimolar concentrations of ß-mercaptoethanol (ß-ME) 
in vitro while the dependence of the hydrolase reaction on ß-ME 
is speculated to be unlikely in vivo. Therefore, although it is 
not clear at present why hydrolase reaction is not affected by 
acetaldehyde in vitro, high level of ß-ME in assay media may 
result in essentially no change in the hydrolase activity in the 
presence of acetaldehyde in this study. 
Although we are unaware of the mechanism how acetaldehyde 
inhibits FDH, there is increasing evidence that the development 
of alcohol-related toxicity may involve the formation of protein 
adducts, which are post-translational modified proteins formed 
by covalent linkage of acetaldehyde to proteins (Donohue et al., 
1983; Worrall & Thiele, 2001). In alcohol toxicity, it was 
suggested that protein adducts may perturb tissue metabolism by 
inactivating the affected proteins (Chen et al., 2000), and the 
affected proteins are more susceptible to proteolysis (Nicholls 
et al., 1994). Pumford et al. (1997) showed that covalent binding 
of high dose of acetaminophen to FDH was toxic to liver and 
proposed that the acetaminophen reactive metabolite may bind 
to sulfhydryl groups of an essential cysteine (cys-707) at the 
active site of the enzyme. Because FDH has an essential cysteine 
(cys-707) at the active site (Cook & Wagner, 1995), conversion 
of cys-707 to alanine in FDH by site-directed mutagenesis led 
to a complete loss of NADP
+-dependent dehydrogenase (Krupenko 
et al., 1995). 
The results of present study show that ethanol does not inhibit 
FDH directly and acetaldehyde inhibits FDH activity, providing 
an explanation for the observed inhibition of FDH activity by 
chronic administration of ethanol to rats. How acetaldehyde 
decreases the enzyme activity and plays a role in ethanol 
hepatotoxicity remains to be investigated further. 
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